Journal article
[Exploration and practice of post-marketing survival benefit evaluation of Chinese patent medicine for cancer].
Abstract
Traditional Chinese medicine(TCM) is an important feature of cancer treatment in China. The methods to tap the advantages of TCM, reasonably evaluate and accurately apply Chinese patent medicines have become current research hotspots and difficulties. TCM takes syndrome differentiation and treatment as the core, with the characteristics of overall regulation and multi-targets efficacy. Therefore, the post-marketing survival benefit evaluation …
Authors
Xu B-W; Wu J-Y; Li J; Zhang Y; Cao L-C; Zhang X-X; Gao R-K
Journal
China Journal of Chinese Materia Medica, Vol. 46, No. 8, pp. 1980–1987
Publication Date
April 2021
DOI
10.19540/j.cnki.cjcmm.20210205.502
ISSN
1001-5302